Last call: OWL’s 2022 Business & Leadership Trends Survey
May 19, 2022
Participate by May 20 in the annual Ophthalmic Business and Leadership Trends Survey for 2022.
May 20, 2022
Tennessee Academy of Ophthalmology’s doctor of the month shares what excites him about ophthalmology, his biggest career challenge, and chocolate as his favorite comfort food.
May 19, 2022
Participate by May 20 in the annual Ophthalmic Business and Leadership Trends Survey for 2022.
May 02, 2022
Expansion of program aims to provide more children with improved eye care; enhance the teaching of Wills residents and fellows
April 27, 2022
Video
The Cleveland Eye Bank Foundation's 2nd Annual Golf Tournament, "Keep Your Eye on the Ball," is happening Monday, June 20, at Pine Hills Golf Club.
April 23, 2022
Video
Richard L. Lindstrom, MD, of Minnesota Eye Consultants, discusses his ASCRS presentation, "Randomized, Open-Label, Parallel-Group Study of Two Dosing Regimens of Netarsudil in Patients with Fuchs Corneal Dystrophy," with Ophthalmology Times' Sheryl Stevenson.
April 23, 2022
Video
For the first time, Orasis Pharmaceutical's phase 2b data for the company's novel candidate for the treatment of presbyopia, CSF-1, a preservative-free solution that contains a proprietary combination of low-dose pilocarpine and multi-faceted vehicle, will be presented during ASCRS by Marjan Farid, MD, and Preeya Gupta, MD. The company recently released its phase 3 topline results. Orasis' Paul Smith, president and COO, talks with Ophthalmology Times' Sheryl Stevenson about this data and the findings' relevance to patients and providers.